Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Jan 31, 2017 | $56.0B |
| FY2018, ended Jan 31, 2018 | $83.3B |
| FY2019, ended Jan 31, 2019 | $117B |
| FY2020, ended Jan 31, 2020 | $163B |
| FY2021, ended Jan 31, 2021 | $208B |
| FY2022, ended Jan 31, 2022 | $230B |
| FY2023, ended Jan 31, 2023 | $168B |
| FY2024, ended Jan 31, 2024 | $273B |
| FY2025, ended Jan 31, 2025 | $328B |
| FY2026, ended Jan 31, 2026 | $196B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $151B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Jan 31, 2017 | $8.44B |
| FY2018, ended Jan 31, 2018 | $10.5B |
| FY2019, ended Jan 31, 2019 | $13.3B |
| FY2020, ended Jan 31, 2020 | $17.1B |
| FY2021, ended Jan 31, 2021 | $21.3B |
| FY2022, ended Jan 31, 2022 | $26.5B |
| FY2023, ended Jan 31, 2023 | $31.4B |
| FY2024, ended Jan 31, 2024 | $34.9B |
| FY2025, ended Jan 31, 2025 | $37.9B |
| FY2026, ended Jan 31, 2026 | $41.5B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $43.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Jan 31, 2017 | $323M | $1.70B |
| FY2018, ended Jan 31, 2018 | $360M | $2.20B |
| FY2019, ended Jan 31, 2019 | $1.11B | $2.80B |
| FY2020, ended Jan 31, 2020 | $126M | $3.69B |
| FY2021, ended Jan 31, 2021 | $4.07B | $4.09B |
| FY2022, ended Jan 31, 2022 | $1.44B | $5.28B |
| FY2023, ended Jan 31, 2023 | $208M | $6.31B |
| FY2024, ended Jan 31, 2024 | $4.14B | $9.50B |
| FY2025, ended Jan 31, 2025 | $6.20B | $12.4B |
| FY2026, ended Jan 31, 2026 | $7.46B | $14.4B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $9.66B | $15.2B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Jan 31, 2017 | $1.61B |
| FY2018, ended Jan 31, 2018 | $2.54B |
| FY2019, ended Jan 31, 2019 | $2.67B |
| FY2020, ended Jan 31, 2020 | $4.14B |
| FY2021, ended Jan 31, 2021 | $6.20B |
| FY2022, ended Jan 31, 2022 | $5.46B |
| FY2023, ended Jan 31, 2023 | $7.02B |
| FY2024, ended Jan 31, 2024 | $8.47B |
| FY2025, ended Jan 31, 2025 | $8.85B |
| FY2026, ended Jan 31, 2026 | $7.33B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $8.31B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Jan 31, 2017 | $2.01B |
| FY2018, ended Jan 31, 2018 | $1.73B |
| FY2019, ended Jan 31, 2019 | $3.20B |
| FY2020, ended Jan 31, 2020 | $2.69B |
| FY2021, ended Jan 31, 2021 | $2.68B |
| FY2022, ended Jan 31, 2022 | $10.6B |
| FY2023, ended Jan 31, 2023 | $10.6B |
| FY2024, ended Jan 31, 2024 | $9.43B |
| FY2025, ended Jan 31, 2025 | $8.43B |
| FY2026, ended Jan 31, 2026 | $14.4B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $39.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 16.3% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Jan 31, 2017 | 708M |
| FY2018, ended Jan 31, 2018 | 732M |
| FY2019, ended Jan 31, 2019 | 771M |
| FY2020, ended Jan 31, 2020 | 895M |
| FY2021, ended Jan 31, 2021 | 921M |
| FY2022, ended Jan 31, 2022 | 990M |
| FY2023, ended Jan 31, 2023 | 1.00B |
| FY2024, ended Jan 31, 2024 | 970M |
| FY2025, ended Jan 31, 2025 | 961M |
| FY2026, ended Jan 31, 2026 | 923M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | 823M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2017, ended Jan 31, 2017 | — | $820M | $1.19B |
| FY2018, ended Jan 31, 2018 | — | $997M | $12.0M |
| FY2019, ended Jan 31, 2019 | — | $1.28B | $2.19B |
| FY2020, ended Jan 31, 2020 | — | $1.78B | $15.6B |
| FY2021, ended Jan 31, 2021 | $0 | $2.19B | — |
| FY2022, ended Jan 31, 2022 | $0 | $2.78B | $11.3B |
| FY2023, ended Jan 31, 2023 | $4.00B | $3.28B | — |
| FY2024, ended Jan 31, 2024 | $7.62B | $2.79B | — |
| FY2025, ended Jan 31, 2025 | $7.83B | $3.18B | — |
| FY2026, ended Jan 31, 2026 | $12.6B | $3.51B | — |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $35.1B | $3.67B | — |
Valuation
At current price- Market Cap
- $198B
- P/E
- 20.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.5×
- Price / Book
- 5.2×
- EV / EBITDA
- 22.4×
Growth
Trailing 12 months- Revenue (TTM)
- $43.9B
- Revenue Growth YoY
- 11.2%
- Revenue CAGR 3Y
- 9.8%
- Revenue CAGR 5Y
- 14.3%
- EPS Growth YoY
- 58.7%
- Net Income Growth YoY
- 45.0%
Profitability
Trailing 12 months- Gross Margin
- 77.3%
- Operating Margin
- 19.9%
- Net Margin
- 22.0%
- FCF Margin
- 34.5%
- Return on Equity
- 19.4%
Earnings
Trailing 12 months- Net Income
- $9.66B
- EPS (diluted)
- $10.92
- EBITDA
- $10.2B
- Operating Income
- $8.73B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $8.31B
- Total Debt
- $39.3B
- Net Debt
- $31.0B
- Total Assets
- $110B
- Total Liabilities
- $71.2B
- Shareholders' Equity
- $38.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $15.8B
- Capital Expenditure
- $596M
- Free Cash Flow
- $15.2B
Dividends and risk
Last 12 months- Dividend Yield
- 0.7%
- Dividend / Share
- $1.74
- Beta (5Y)
- 1.25
Every ratio is calculated from the company’s reported figures.